Physician profile
Kellis Bulleigh
NPI 1063679066
$7,149.75
in general payments reported to CMS, 2019-2025
18 companies · $1,730 in 2025
The $1,730 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $697 · 2021: $1,536 · 2022: $2,517 · 2023: $488 · 2024: $182 · 2025: $1,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,249 · Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,248.77 |
| Food and Beverage | $1,151.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $4,453.83 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $1,746.42 | 2023-2025 | Oxford, Comprehensive Shoulder System |
| Ferring Pharmaceuticals INC. | $276.34 | 2021-2025 | Euflexxa |
| Stryker Corporation | $231.46 | 2021-2023 | Mako |
| Bioventus LLC | $58.45 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $53.08 | 2021-2025 | Pico 14 |
| Pacira Therapeutics, INC. | $49.92 | 2021 | |
| Horizon Therapeutics Plc | $39.47 | 2022 | |
| Acumed LLC | $36.92 | 2024 | Acumed, Innate Implant |
| Depuy Synthes Sales INC. | $34.75 | 2021 | |
| Ermi LLC | $33.35 | 2020 | |
| Inspire Medical Systems, INC. | $27.13 | 2024 | Inspire |
| Organogenesis INC. | $24.71 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.97 | 2023 | Exparel, Iovera, Zilretta |
| Linvatec Corporation | $17.40 | 2025 | Biobrace 23mm, Y-Knot, Anchor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.88 | 2021 | |
| Innovation Technologies INC | $14.87 | 2024 | Irrisept |
| Fidia Pharma USA INC. | $12.80 | 2023 | Hym/Hyn |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellis Bulleigh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.